Studies agree on the best blood glucose levels for diabetics with kidney failure

November 10, 2011 in Diseases, Conditions, Syndromes

Two separate studies presented during the American Society of Nephrology's Annual Kidney Week agree that diabetics with kidney failure shouldn't lower their blood glucose levels as much as diabetics without kidney failure.

For most patients with diabetes, taking medication to lowering blood levels of hemoglobin A1C, which reflect average , to <7% can lower their risk of developing certain complications. Sylvia Paz Ramirez, MD (Arbor Research Collaborative For Health) and her colleagues wondered whether this holds true for diabetic patients who have developed .

The researchers analyzed data from 8,437 from 12 countries who had diabetes. They found that the lowest risk of death during the study occurred when hemoglobin A1C levels were between 7% and 8%. Both high and low levels were linked with increased rates of death, particularly for patients with levels of 9% or higher or less than 5%. Among patients with A1C levels below 7%, death rates were higher among patients taking .

In a similar study, Miklos Molnar MD, PhD (Semmelweis University, in Budapest, Hungary) and his team examined death rates among 54,757 diabetic patients treated at DaVita dialysis clinics from July 2001 through June 2006 with follow-up through June 2007. They found a link between high and hemoglobin A1C levels of 8% or greater. Very low levels also increased patients' risk of dying during the study.

These results indicate that unlike for most patients with diabetes, diabetics with kidney failure benefit the most when their hemoglobin A1C levels are between 7% and 8%, although clinical trials are needed to definitely determine the optimal range.

More information: Study authors for "Hemoglobin A1C Levels and Mortality in the ESRD Population: Findings from the DOPPS" (abstract TH-OR065) include Sylvia Paz Ramirez, MD, Jyothi Thumma, Francesca Tentori, MD, Brenda Gillespie, PhD, Masaaki Inaba, MD, PhD, Robert Nelson, MD, PhD, Ronald Pisoni, PhD, and Bruce Robinson, MD.

Study authors for "Glycemic Control and Mortality in Hemodialysis Patients with Diabetes Mellitus: A Six Year Cohort Study" (abstract TH-OR085) include Miklos Molnar, MD, PhD, Joni Ricks, Csaba Kovesdy, MD, Anuja Shah, MD, Allen Nissenson, MD, Mark Williams, MD, and Kamyar Kalantar-Zadeh, MD, PhD.

Provided by American Society of Nephrology search and more info website

5 /5 (1 vote)  

Rank 5 /5 (1 vote)
Relevant PhysicsForums posts

More news stories

FDA warns of infections tied to Tennessee pharmacy

(AP)—Government health officials are investigating several health problems reported with potentially contaminated medications made by a Tennessee specialty pharmacy.

Diseases, Conditions, Syndromes created 20 hours ago | popularity not rated yet | comments 0

Comorbidities common with alopecia areata

(HealthDay)—Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.

Diseases, Conditions, Syndromes created 21 hours ago | popularity not rated yet | comments 0

Top-ranked golfer beats scoliosis

(HealthDay)—As a world-class golfer, Stacy Lewis' accomplishments are remarkable. But it was a physical challenge in her childhood that defined her ascent to the top of her sport.

Diseases, Conditions, Syndromes created 22 hours ago | popularity not rated yet | comments 0

Saudi to send animal samples to US in coronavirus probe (Update)

Saudi Arabia said Friday it would send samples taken from animals possibly infected with a deadly SARS-like virus to the United States for testing in a bid to find the source of disease.

Diseases, Conditions, Syndromes created May 24, 2013 | popularity not rated yet | comments 0

WHO voices deep concern over spread of SARS-like virus

The World Health Organization voiced deep concern Thursday over the SARS-like virus that has killed 22 people in less than a year, saying it might potentially spread more widely between humans.

Diseases, Conditions, Syndromes created May 24, 2013 | popularity 5 / 5 (1) | comments 0


First drug to improve heart failure mortality in over a decade

Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...

Hormone levels may provide key to understanding psychological disorders in women

Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.

Heart failure accelerates male 'menopause'

Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...

Researchers identify first drug targets in childhood genetic tumor disorder

Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...

Going live: Immune cell activation in multiple sclerosis

Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...

Feds fight morning-after pill age ruling in NY

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...